These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6387105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Dalton L, Bunney WE.
    Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
    [Abstract] [Full Text] [Related]

  • 6. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR, Dougherty D, Sethuraman G, Vrindavanam N.
    Biol Psychiatry; 1996 Nov 15; 40(10):1044-50. PubMed ID: 8915564
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R, Mackie M, Morrison D, Kidd J.
    Br J Psychiatry; 1982 Mar 15; 140():280-6. PubMed ID: 7093596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum prolactin and antipsychotic responses to pimozide in schizophrenia.
    Siris SG, van Kammen DP, De Fraites EG.
    Psychopharmacol Bull; 1978 Jan 15; 14(1):11-4. PubMed ID: 625528
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
    van Kammen DP, Docherty JP, Marder SR, Schulz SC, Bunney WE.
    Arch Gen Psychiatry; 1980 Mar 15; 37(3):287-90. PubMed ID: 6102456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pimozide in the treatment of newly admitted schizophrenic patients.
    Chouinard G, Annable L.
    Psychopharmacology (Berl); 1982 Mar 15; 76(1):13-9. PubMed ID: 6805002
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie RG, Dingwall JM, Wiles DH, Heykants JJ.
    Br J Psychiatry; 1980 Dec 15; 137():510-7. PubMed ID: 7011468
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.